Literature DB >> 11081596

Embryological development and large vestibular aqueduct syndrome.

G M Pyle1.   

Abstract

OBJECTIVES/HYPOTHESIS: Large vestibular aqueduct syndrome (LVAS) is a significant cause of hearing loss in early childhood. Many theories on the origins and causes of LVAS have been proposed, including arrest or maldevelopment of the vestibular labyrinth in embryonic life. Prior studies have described postnatal and adult vestibular aqueduct anatomy, but none has analyzed aqueduct growth throughout embryonic life. This study was undertaken to characterize the growth of the developing vestibular aqueduct to gain a better understanding of the possible origins of LVAS. STUDY
DESIGN: Basic science, temporal bone histopathological study.
METHODS: Serial sections from 48 temporal bones from human embryos ranging in age from 5 weeks' gestation to full term were studied with computer image analysis. Measurements of vestibular aqueduct internal and external aperture, midportion diameter, and length were analyzed to obtain a growth model of development.
RESULTS: The vestibular aqueduct grows in a nonlinear fashion throughout embryonic life. All parameters fit a similar growth curve and never reached a maximum or began narrowing during development. Growth in one parameter correlated well with growth of another. There was good side-to-side correlation with all but the external aperture.
CONCLUSIONS: Most of the membranous labyrinth reaches adult size by 20 weeks' gestation, but the vestibular aqueduct grows throughout embryonic life. The measurements and growth model obtained in this study are not consistent with the theory that LVAS results from an arrest in development early in fetal life. The data suggest that LVAS may result from postnatal and early childhood maldevelopment.

Entities:  

Mesh:

Year:  2000        PMID: 11081596     DOI: 10.1097/00005537-200011000-00014

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

1.  [Large endolymphatic duct and sac syndrome (LEDS) : part I: analysis of imaging findings].

Authors:  S Bartel-Friedrich; B Amaya; C Rasinski; M Fuchs; S Kösling
Journal:  HNO       Date:  2008-02       Impact factor: 1.284

2.  SLC26A4 mutation testing for hearing loss associated with enlargement of the vestibular aqueduct.

Authors:  Taku Ito; Julie Muskett; Parna Chattaraj; Byung Yoon Choi; Kyu Yup Lee; Christopher K Zalewski; Kelly A King; Xiangming Li; Philine Wangemann; Thomas Shawker; Carmen C Brewer; Seth L Alper; Andrew J Griffith
Journal:  World J Otorhinolaryngol       Date:  2013-05-28

Review 3.  Review of congenital inner ear abnormalities on CT temporal bone.

Authors:  R S Z Yiin; P H Tang; T Y Tan
Journal:  Br J Radiol       Date:  2011-09       Impact factor: 3.039

4.  Can a fixed measure serve as a pertinent diagnostic criterion for large vestibular aqueduct in children?

Authors:  Marc Legeais; Ken Haguenoer; Jean Philippe Cottier; Dominique Sirinelli
Journal:  Pediatr Radiol       Date:  2006-07-25

5.  Inner ear abnormalities in four patients with dRTA and SNHL: clinical and genetic heterogeneity.

Authors:  Elena Andreucci; Benedetta Bianchi; Ilaria Carboni; Giancarlo Lavoratti; Marzia Mortilla; Claudio Fonda; Minna Bigozzi; Maurizio Genuardi; Sabrina Giglio; Ivana Pela
Journal:  Pediatr Nephrol       Date:  2009-07-29       Impact factor: 3.714

6.  Enlarged vestibular aqueduct in congenital non-syndromic sensorineural hearing loss in egypt.

Authors:  Maha Abou-Elew; Mostafa El-Khousht; Mohamed Sherif El-Minawi; Mona Selim; Ayman Ismail Kamel
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-12-27

7.  Sudden Sensorineural Hearing Loss in the Only Hearing Ear: Large Vestibular Aqueduct Syndrome.

Authors:  Kemal Koray Bal; Onur Ismi; Helen Bucioglu; Yusuf Vayısoğlu; Kemal Gorur
Journal:  Case Rep Otolaryngol       Date:  2016-11-27

8.  The Relationship Between the Third Window Abnormalities and Inner Ear Malformations in Children with Hearing Loss.

Authors:  Fatma Ceren Sarioglu; Yeliz Pekcevik; Handan Guleryuz; Asli Cakir Cetin; Enis Alpin Guneri
Journal:  J Int Adv Otol       Date:  2021-09       Impact factor: 1.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.